VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
OHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
OHIOmega Healthcare Investors, Inc.
$48.19$14.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. OHI
  4. Financial Ratios

Omega Healthcare Investors, Inc. (OHI) Financial Ratios

Latest Ratios: P/E Ratio 20.3x · EV/EBITDA 17.7x · ROE 11.6%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

OHI Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$14.4B$13.8B$10.2B$7.7B$6.8B$7.2B$8.5B$9.4B$7.4B$5.7B$6.3B
Enterprise Value$18.6B$18.0B$14.6B$12.3B$11.8B$12.5B$13.5B$14.5B$11.9B$10.2B$10.6B
P/E Ratio →20.3122.8624.4230.6615.5316.9153.4127.5026.2354.0016.45
P/S Ratio10.8611.509.748.097.776.809.5710.138.366.277.00
P/B Ratio2.752.532.162.041.801.762.122.171.961.461.50
P/FCF17.1615.6814.3613.0511.8011.5313.4922.7220.4811.5911.32
P/OCF16.3315.6813.6612.2610.9110.0112.0616.9914.769.8510.07

P/E links to full P/E history page with 30-year chart

OHI EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—15.0313.8512.9513.4611.7315.1815.6313.5011.2111.74
EV / EBITDA17.6616.7515.1015.2116.3113.7217.3217.0115.2816.8912.79
EV / EBIT24.7921.3122.6625.0517.6519.1535.1226.2823.9031.2218.89
EV / FCF—20.4920.4320.9120.4319.8721.3935.0633.0720.7318.99

OHI Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin44.5%44.5%98.6%98.4%98.2%98.8%98.6%98.4%100.0%100.0%100.0%
Operating Margin62.6%62.6%62.7%51.5%44.7%53.3%50.7%59.4%56.4%34.7%62.2%
Net Profit Margin49.3%49.3%38.6%25.5%48.6%39.2%17.9%36.7%31.9%11.1%40.7%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE11.6%11.6%9.6%6.4%10.8%10.2%3.8%8.4%7.4%2.5%8.8%
ROA5.9%5.9%4.3%2.6%4.5%4.4%1.7%3.7%3.2%1.1%4.3%
ROIC6.0%6.0%5.7%4.3%3.2%4.6%3.7%4.7%4.5%2.8%5.2%
ROCE7.9%7.9%7.2%5.5%4.3%6.1%4.9%6.4%6.1%3.8%7.1%

OHI Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.780.781.021.351.391.281.281.181.211.181.04
Debt / EBITDA3.963.965.026.277.305.786.616.025.837.595.28
Net Debt / Equity—0.780.911.231.311.271.241.181.201.151.01
Net Debt / EBITDA3.943.944.485.726.895.766.405.995.827.445.17
Debt / FCF—4.816.067.868.638.357.9112.3512.599.137.67
Interest Coverage3.833.832.902.092.872.771.732.652.471.483.19

OHI Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.463.468.037.255.306.533.642.822.062.562.98
Quick Ratio3.463.468.037.255.306.533.642.822.062.562.98
Cash Ratio0.050.051.581.440.890.070.430.060.020.150.17
Asset Turnover—0.120.110.100.090.110.090.090.100.100.10
Inventory Turnover———————————
Days Sales Outstanding———————————

OHI Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield5.2%5.7%6.7%8.4%9.3%8.8%7.2%6.0%7.2%8.8%7.2%
Payout Ratio132.2%132.2%168.7%265.9%148.2%153.0%384.3%165.4%187.8%500.5%123.7%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.9%4.4%4.1%3.3%6.4%5.9%1.9%3.6%3.8%1.9%6.1%
FCF Yield5.8%6.4%7.0%7.7%8.5%8.7%7.4%4.4%4.9%8.6%8.8%
Buyback Yield0.0%0.0%0.0%0.0%2.1%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield5.2%5.7%6.7%8.4%11.4%8.8%7.2%6.0%7.2%8.8%7.2%
Shares Outstanding—$311M$270M$250M$244M$244M$235M$222M$210M$207M$202M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Tenant solvency and payout coverage

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Premium Multiples Lack FFO Anchor

Based on reported figures, OHI trades at a 24.74x trailing P/E and 17.23x EV/EBITDA, while P/FFO and P/AFFO remain unavailable, leaving the stock's valuation dependent on earnings measures that poorly reflect REIT cash generation.

The reported P/FFO of 17.95x on the most recent quarter, derived from quarterly FFO per share, suggests a more grounded multiple than the trailing P/E, which is distorted by depreciation and quarterly timing effects. The implied yield of 5.2% sits above the peer median, which may indicate the market is pricing in tenant-solvency risk rather than rewarding current growth. Investors should monitor whether the multiple compresses as FFO normalizes after the volatile 2026Q2 quarter.

Payout Coverage Swings Above and Below Parity

As reported in financial statements, OHI's FFO payout ratio moved from 45.0% in 2026Q2 to 125.3% in 2026Q3, indicating that dividend coverage has been inconsistent across the latest two quarters.

Payout ratios above 100% in 2025Q1 and 2026Q3 suggest the dividend was not fully covered by FFO in those periods, and the trailing average over the ten quarters sits near 85%, leaving a thin retention buffer. The AFFO-based coverage tells a similar story, with the 2026Q2 figure looking exceptional against a weaker following quarter. Investors should monitor whether sustained payout ratios above 90% force retained-cash constraints or reliance on external funding.

Deleveraging Progress Tempered by Volatility

Based on EDBL's reported figures, OHI's debt-to-equity ratio declined from a peak of 1.19 in 2024Q2 to 0.70 in 2026Q3, while interest coverage moved erratically between 2.92x and 8.99x across the period.

The reduction in leverage is consistent with the debt paydown reported on the balance sheet, though the debt-to-equity measure uses book equity rather than gross assets, so it may understate true leverage relative to property values. Interest coverage swings appear driven more by quarterly earnings timing than by a structural change in debt cost, and the latest 2.92x reading warrants closer monitoring. Refinancing exposure and maturity profile were not supplied in the data and should be reviewed before drawing firm conclusions on balance sheet resilience.

NOI Margin Distorted by Recognition Timing

According to recent SEC filings, OHI's reported NOI margin ranged from 46.4% in 2026Q2 to 98.9% in 2025Q3, a dispersion that appears to reflect accounting recognition patterns rather than underlying property economics.

Margins clustered near 98% for most quarters, with the 2026Q2 and 2025Q4 readings sitting far below that band, which suggests straight-line rent or non-accrual adjustments rather than operating deterioration. FFO per share growth of 104.8% in 2026Q2 followed by a decline to $0.51 indicates that headline profitability is highly sensitive to non-recurring items. Investors should look through the quarterly noise toward the multi-quarter FFO trend, which is more representative of recurring earnings power.

Peer Multiples Mislead on Depreciation Effects

The standard P/E ratio that appears to show OHI at 24.74x is commonly misapplied to healthcare REITs, because depreciation and impairment charges depress net income and inflate the multiple relative to cash earnings.

Applying P/E or EV/EBITDA to OHI obscures the cash flow generated by its triple-net leases, and the 2026Q2 earnings beat illustrates how one-time gains can distort the picture. The more appropriate measure is P/FFO or P/AFFO, which adds back real estate depreciation and reflects recurring rental cash flow. Investors should replace P/E with P/AFFO once AFFO per share is consistently reported across all quarters.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open OHI Terminal

OHI Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

OHI — Frequently Asked Questions

Quick answers to the most common questions about buying OHI stock.

What is Omega Healthcare Investors, Inc.'s P/E ratio?

Omega Healthcare Investors, Inc.'s current P/E ratio is 20.3x. The historical average is 28.5x. This places it at the 31th percentile of its historical range.

What is Omega Healthcare Investors, Inc.'s EV/EBITDA?

Omega Healthcare Investors, Inc.'s current EV/EBITDA is 17.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 16.2x.

What is Omega Healthcare Investors, Inc.'s ROE?

Omega Healthcare Investors, Inc.'s return on equity (ROE) is 11.6%. The historical average is 7.0%.

Is OHI stock overvalued?

Based on historical data, Omega Healthcare Investors, Inc. is trading at a P/E of 20.3x. This is at the 31th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Omega Healthcare Investors, Inc.'s dividend yield?

Omega Healthcare Investors, Inc.'s current dividend yield is 5.21% with a payout ratio of 132.2%.

What are Omega Healthcare Investors, Inc.'s profit margins?

Omega Healthcare Investors, Inc. has 44.5% gross margin and 62.6% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does Omega Healthcare Investors, Inc. have?

Omega Healthcare Investors, Inc.'s Debt/EBITDA ratio is 4.0x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.